Therefore, a comprehensive meta-analysis of all eligible articles was performed to further evaluate the clinical feasibility of NEAT1 as a novel biomarker candidate as well as useful insights into the tumor clinicopathological features. The gene discussed is NEAT1; the disease is neoplasm.